A notable example is the Asia-Pacific (APAC) Innovation Center of renewable and circular solutions provider Neste, located at Singapore Science Park 2. The adaptable and spacious environment has enabled Neste to accommodate a wide range of laboratory equipment, crucial for advancing its analytical and raw material research capabilities, said Ms Leena Matilainen, the centre’s head.
Flexibility is also a key advantage for Avaya. “The offices are spacious, with excellent meeting rooms and ample space to support future expansion; we find it to be good value for money too,” said Mr Sirohi.
More than just a collection of workspaces, Singapore Science Park’s lively community of science, technology and business leaders creates an environment rich with opportunities for collaborative growth. Ms Teo added that Geneo, the newest S$1.4 billion life sciences and innovation cluster of five Grade A buildings at the park, will further strengthen community connections, providing spaces for networking, socialising and unwinding.
Geneo enhances work-live-play offerings with business-friendly amenities like co-working labs and the park’s first lodging facility, Citadines Science Park Singapore. It also includes a fitness corner, end-of-trip facilities and a weather-proof, naturally ventilated event plaza with three levels of dining, retail and entertainment options, directly connected to Kent Ridge MRT station.
Further driving the biotech ecosystem forward, NSG BioLabs is joining forces with CapitaLand to launch a new biotech co-working hub at Geneo. Designed to ignite greater collaboration among life science and deep tech companies, the facility offers flexible workspaces, shared wet labs as well as a fully equipped meeting and conference venue. This expansion will increase NSG BioLabs’ footprint to over 70,000 sq ft, solidifying its position as the region’s largest co-working biotech laboratory.
A STRATEGICALLY POSITIONED ECOSYSTEM
“Singapore serves as a gateway to Southeast Asia and is highly accessible to the wider Asia-Pacific region,” observed Mr Keng Hock Chua, managing director of Merck Singapore and vice president of Process Solutions (Asia Pacific), Life Science Business at Merck. He noted Singapore’s evolution into a flourishing biomedical sciences hub, recognised for its strong research and development capabilities and pool of skilled talent.
“Singapore Science Park hosts numerous leading research institutions, pharmaceutical and biotech companies,” said Mr Chua. “This proximity facilitates closer collaboration with our life science customers and contributes to an innovation-driven ecosystem.”
These factors were pivotal in Merck’s decision to establish its regional headquarters, life science lab facilities and the first Good Manufacturing Practices BioReliance biosafety testing lab outside the United States and United Kingdom at The Ascent, Singapore Science Park.